The impact of human epidermal growth factor receptor-2 status of invasive breast tumors on thermography findings

被引:0
|
作者
Zore, Zvonimir [1 ]
Boras, Ivanka [2 ]
Filipovic-Zore, Irina [3 ]
Stanec, Mladen [1 ]
Lesar, Miroslav [1 ]
Vrdoljak, Danko V. [1 ]
机构
[1] Univ Clin Hosp Ctr, Dept Surg Oncol, Zagreb 197, Croatia
[2] Univ Sch Mech Engn & Naval Architecture, Dept Thermodynam, Zagreb, Croatia
[3] Univ Zagreb, Sch Dent Med, Dept Oral Surg, Zagreb 41000, Croatia
关键词
CANCER;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyze the impact of the prognostic human epidermal growth factor receptor-2 (HER-2) in invasive breast cancers on the findings of thermography tests. Methods: This study was carried out at the Department of Surgical Oncology and the Department of Pathology, University Clinical Hospital Center, "Sisters of Mercy", Zagreb, Croatia, in collaboration with licensed infrared (IR) thermography experts. The study involved 75 female patients diagnosed with invasive breast cancer from May to July 2011. Thermography findings were compared between different immune-histochemical (IHC) findings (HER-2 status: positive or negative). Results: Significantly higher temperatures were recorded in invasive cancer breasts than in healthy breasts. The cancer sites and the entire cancer breasts were significantly warmer (p<0.001) than the healthy breasts and opposite tumors mirror sites. Considering the HER-2 status, HER-2 positive invasive cancers were significantly warmer in comparison with the HER-2 negative cancers (p=0.035). Conclusion: The trend of increased temperature in HER-2+ tumors was noted. The findings clearly indicate that HER-2+ status has a higher impact on the increased thermographic temperature findings. Saudi Med J 2012; Vol. 33 (10): 1118-1121
引用
收藏
页码:1118 / 1121
页数:4
相关论文
共 50 条
  • [21] Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors
    Groheux, David
    Hatt, Mathieu
    Hindie, Elif
    Giacchetti, Sylvie
    de Cremoux, Patricia
    Lehmann-Che, Jacqueline
    Martineau, Antoine
    Marty, Michel
    Cuvier, Caroline
    Cheze-Le Rest, Catherine
    de Roquancourt, Anne
    Visvikis, Dimitris
    Espie, Marc
    CANCER, 2013, 119 (11) : 1960 - 1968
  • [22] Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer
    Henry, Kelly E.
    Ulaner, Gary A.
    Lewis, Jason S.
    PET CLINICS, 2018, 13 (03) : 423 - +
  • [23] Screening Human Epidermal Growth Factor Receptor-2 Inhibitors From Natural Products
    Liu, Xiujie
    Jia, Shaohua
    Dai, Rongji
    Deng, Yulin
    Lv, Fang
    2013 ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING (CME), 2013, : 497 - 500
  • [24] Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer
    Yiting Geng
    Xiaofeng Chen
    Jinrong Qiu
    Yue Zhou
    Jian Wang
    Lingxiang Liu
    Yongfeng Shao
    Yongmei Yin
    International Journal of Clinical Oncology, 2014, 19 : 303 - 311
  • [25] Advances in targeting human epidermal growth factor receptor-2 signaling for cancer therapy
    Meric-Bernstam, Funda
    Hung, Mien-Chie
    CLINICAL CANCER RESEARCH, 2006, 12 (21) : 6326 - 6330
  • [26] Inhibition of human epidermal growth factor receptor-2 protein by some alkaloid inhibitors
    Razavi, Leila
    Raissi, Heidar
    JOURNAL OF MOLECULAR LIQUIDS, 2024, 410
  • [27] The impact of human epidermal growth factor receptor-2 (low) status on the efficacy of first line cyclin-dependent kinase 4/6 inhibitors in advanced breast cancer
    Yildirim, Hasan Cagri
    Buyukkor, Mustafa
    Kavgaci, Gozde
    Celik, Buket Sahin
    Yucel, Kadriye Bir
    Dursun, Bengu
    Chalabiyev, Elvin
    Yilmaz, Funda
    Yildirim, Saadet Sim
    Kus, Fatih
    Tay, Fatih
    Gecgel, Asli
    Koksal, Baris
    Guven, Deniz Can
    Yazici, Ozan
    Urun, Yueksel
    Ozet, Ahmet
    Gokmen, Erhan
    Oksuzoglu, Berna
    Aksoy, Sercan
    MEDICINE, 2024, 103 (30)
  • [28] Estrogen receptor-negative invasive breast cancer: Imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression
    Wang, Yingbing
    Ikeda, Debra M.
    Narasimhan, Balasubramanian
    Longacre, Teri A.
    Bleicher, Richard J.
    Pal, Sunita
    Jackman, Roger J.
    Jeffrey, Stefanie S.
    RADIOLOGY, 2008, 246 (02) : 367 - 375
  • [29] Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer
    Geng, Yiting
    Chen, Xiaofeng
    Qiu, Jinrong
    Zhou, Yue
    Wang, Jian
    Liu, Lingxiang
    Shao, Yongfeng
    Yin, Yongmei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (02) : 303 - 311
  • [30] The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker
    Cooke, T
    Reeves, J
    Lannigan, A
    Stanton, P
    EUROPEAN JOURNAL OF CANCER, 2001, 37 : S3 - S10